News
Biogen has unveiled plans to invest an additional $2bn in its existing manufacturing footprint in North Carolina, US. The ...
With the threat of tariffs looming for medicines imported to the United States, AstraZeneca has unveiled a plan to invest $50 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback